On 2024-11-07, Skye Bioscience, Inc. (SKYE) announced earnings per share of $-0.22 for the fiscal quarter ending 2024-09-30, beating the average analyst estimate of $-0.26.
The next expected annoucement date for quarterly earnings is 2025-03-28, with an average estimated earnings per share of $-0.30 for the fiscal quarter ending 2024-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-07 | 2024-09-30 | $-0.26 | $-0.22 |
| 2024-08-09 | 2024-06-30 | $-0.20 | $-0.20 |
| 2024-05-10 | 2024-03-31 | $-0.16 | $-0.18 |
| 2023-11-13 | 2023-09-30 | -- | $-3.17 |
| 2023-08-07 | 2023-06-30 | -- | $0.00 |
| 2023-05-11 | 2023-03-31 | -- | $-2.50 |
| 2023-03-31 | 2022-12-31 | -- | $-5.00 |
| 2022-11-14 | 2022-09-30 | -- | $-2.50 |
| 2022-08-15 | 2022-06-30 | -- | $-2.50 |
| 2022-05-06 | 2022-03-31 | -- | $-2.50 |
| 2022-03-25 | 2021-12-31 | -- | $0.00 |
| 2021-11-10 | 2021-09-30 | -- | $0.00 |
| 2021-08-06 | 2021-06-30 | -- | $-2.50 |
| 2021-05-07 | 2021-03-31 | -- | $-2.50 |
| 2020-08-13 | 2020-06-30 | -- | $-2.50 |
| 2020-05-08 | 2020-03-31 | -- | $-2.50 |
| 2020-03-20 | 2019-12-31 | -- | $-17.50 |
| 2019-11-14 | 2019-09-30 | -- | $-10.00 |
| 2019-08-09 | 2019-06-30 | -- | $20.00 |
| 2019-05-09 | 2019-03-31 | -- | $-7.50 |
| 2019-03-14 | 2018-12-31 | -- | $-12.50 |
| 2018-11-13 | 2018-09-30 | -- | $-5.00 |
| 2018-08-10 | 2018-06-30 | -- | $-5.00 |
| 2018-05-15 | 2018-03-31 | -- | $-22.50 |
| 2017-08-11 | 2017-06-30 | -- | $-5.00 |
| 2017-05-12 | 2017-03-31 | -- | $-22.50 |
| 2017-03-10 | 2016-12-31 | -- | $-17.50 |
| 2016-11-09 | 2016-09-30 | -- | $-12.50 |
| 2016-08-12 | 2016-06-30 | -- | $7.50 |
| 2016-05-13 | 2016-03-31 | -- | $-20.00 |